October 2017 - content-exac-com.staging.exac.com

Exactech Q3 Revenue $61.4 Million; Q3 Net Income $2.9 Million; Diluted EPS $0.20

October 30, 2017

GAINESVILLE, Fla. (Oct. 30, 2017) — Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that…

Exactech Cancels Q3 Earnings Call Previously Scheduled for Tuesday, Oct. 31, 2017

October 25, 2017

Gainesville, Fla. (Oct. 25, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that,…

Exactech Enters Definitive Agreement with TPG Capital to Go Private

October 23, 2017

Leading Healthcare Investor Provides Company with Strategic Growth Capital Exactech Shareholders To Receive $42.00 Per Share In Cash Transaction Values Exactech at $625 Million Represents a Premium of Approximately 31%…

Exactech Comments on Impact of Hurricanes Irma and Harvey. Adjusts Q3 Earnings Guidance and Announces Q3 Earnings Call

October 12, 2017

GAINESVILLE, Fla. (October 12, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, said today it…